Clinical Trial Update: CryoCath Freezor CryoAblation Catheter System (CRYOFACTS) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for the CryoCath Freezor CryoAblation Catheter System (CRYOFACTS) completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrioventricular Nodal Reentrant Tachycardia

Drugs mentioned

• CryoCath Freezor CryoAblation Catheter System (CRYOFACTS)

Snippet

Sponsor: Medtronic Cardiac Rhythm and Heart Failure | Conditions: Tachycardia, Atrioventricular Nodal Reentry | Phase 4 | Status: COMPLETED | Results posted: 2015-04-23